RON tyrosine kinase mutations in brain metastases from lung cancer-Reference-Cited by-同舟云学术

RON tyrosine kinase mutations in brain metastases from lung cancer

Published:2018-01 Issue:1 Volume:4 Page:00083-2017
ISSN:2312-0541
Container-title:ERJ Open Research
language:en
Short-container-title:ERJ Open Res

Author:

Milan Melissa,Benvenuti Silvia,Balderacchi Alice Maria,Virzì Anna Rita,Gentile Alessandra,Senetta Rebecca,Cassoni Paola,Comoglio Paolo Maria,Stella Giulia Maria

Funder

AIRC IG

AIRC Special Program 5xMille 2010 MCO

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference16 articles.

1. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients

2. Correlating symptoms and their changes with survival in patients with brain metastases;Wong;Ann Palliat Med,2016

3. The MET receptor tyrosine kinase in invasion and metastasis

4. MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer: Table 1.

5. Macrophage Stimulating Protein Is a Novel Neurotrophic Factor

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Small Cell Lung Cancer Brain Metastasis: The Link between Molecular Mechanisms and Novel Therapeutic Approaches;Cancer Metastasis - Molecular Mechanism and Clinical Therapy;2023-03-08

2. Advances in the Molecular Landscape of Lung Cancer Brain Metastasis;Cancers;2023-01-24

3. The MST1R/RON Tyrosine Kinase in Cancer: Oncogenic Functions and Therapeutic Strategies;Cancers;2022-04-18

4. A Need for More Molecular Profiling in Brain Metastases;Frontiers in Oncology;2022-01-25

5. The effect of splicing MST1R in gastric cancer was enhanced by lncRNA FENDRR;Experimental and Therapeutic Medicine;2021-05-25